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Objective: Abdominal aortic aneurysm (AAA) management involves a decision process that takes into account anatomic
characteristics, surgical risks, patients’ preferences, and expected survival. Whereas larger AAA diameter has been asso-
ciated with increased mortality after both standard endovascular aneurysm repair (EVAR) and open repair, it is unclear
whether survival after EVAR is influenced by other anatomic characteristics. The purpose of this study was to determine
the importance of baseline anatomic features on survival after EVAR.
Methods: All patients treated at a tertiary teaching center with EVAR for intact standard infrarenal AAA from 2000 to
2014 were included. The civil data registry was queried to determine survival status; causes of death were obtained
from death certificates. The primary study end point was to determine the impact of baseline morphologic features on
all-cause and cardiovascular mortality after EVAR.
Results: This study included 404 EVAR patients (12.1% women; mean age, 73 years) with a median follow-up of 5.8 years
(interquartile range, 3.1-7.4 years). The 5- and 10-year overall survival rates for the entire population after EVAR were 70%
(95% confidence interval [CI], 66%-75%) and 43% (95% CI, 37%-50%), respectively. Only AAA diameter >70 mm (hazard
ratio [HR], 1.75; 95% CI, 1.20-3.56) was identified as an independent anatomic predictor of all-causemortality. Death due to
cardiovascular causes occurred in 60 (38.5%) patients. Aneurysm-related mortality was responsible for six of the
cardiovascular-related deaths. In multivariable analysis, both neck diameter$30mm (HR, 2.16; 95% CI, 1.05-4.43) and AAA
diameter >70 mm (HR, 2.45; 95% CI, 1.34-4.46) were identified as independent morphologic risk factors for cardiovascular
mortality, whereas >25% circumferential neck thrombus (HR, 0.32; 95% CI, 0.13-0.77) was protective.
Conclusions: This study suggests that patients with AAA diameters >70 mm are at increased risk of all-cause and car-
diovascular mortality. In addition, patients with infrarenal neck diameters $30 mm have a greater risk of cardiovascular
mortality, although AAA-related deaths were not more frequent in this group of patients. Consequently, a more
aggressive management of cardiovascular medical comorbidities may be warranted to improve survival after standard
EVAR in these patients. (J Vasc Surg 2019;69:1444-51.)
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Retrospective studiesTreatment of abdominal aortic aneurysms (AAAs)
involves a decision-making process in which the patient’s
comorbidities, the anatomic characteristics, the
procedure-specific outcomes, and the patient’s prefer-
ence are considered along with long-term survival
expectancy. Whereas endovascular aneurysm repair
(EVAR) has become the most common repair method,
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ARTICLE HIGHLIGHTS
d Type of Research: Retrospective, single-center
cohort study
d Key Findings: Endovascular repair of abdominal
aortic aneurysms in 404 patients resulted in 5- and
10-year survival of 70% and 43%. Preoperative aneu-
rysm size>70mmpredicted all-cause and cardiovas-
cular mortality, whereas aneurysm neck diameter
>30 mm predicted cardiovascular mortality.
d Take Home Message: This study suggests that pa-
tients with larger abdominal aortic aneurysms with
larger infrarenal necks have reduced life expectancy
after endovascular aneurysm repair.
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tive AAA diameter and infrarenal neck diameter have
been linked to worse survival.8 Yet the impact of each
of these features separately could not be established.
Aortic thrombus has also been suggested to have a
negative impact on survival, but the available data are
scarce.9 In addition to this, other anatomic characteris-
tics of the aneurysm may also constitute an increased
mortality risk after EVAR.
The purpose of this study was to assess the impact of
baseline anatomic characteristics on long-term survival
after standard EVAR for intact AAAs. In addition, the
association between other patient factors (baseline
demographics, comorbidities) and long-term mortality
was investigated.
METHODS
Design and population. This retrospective study com-
plies with the Declaration of Helsinki in research ethics.
Informed consent was waived according to institutional
policy on retrospective research. All patients undergoing
standard infrarenal EVAR at a high-volume center in The
Netherlands (Erasmus University Medical Center, Rotter-
dam) from January 2000 to December 2014 were
included. Patients with anastomotic, infectious, or iso-
lated iliac aneurysms were excluded from these analyses.
In addition, patients who died during hospitalization for
the initial EVAR or in whom a preoperative computed
tomography (CT) image was no longer retrievable for
analysis were excluded.
Measurements. All morphologic measurements were
performed by two observers experienced in image anal-
ysis (N.F.G.O., F.B.G.) using dedicated postprocessing soft-
ware (3mensio Vascular, Bilthoven, The Netherlands)
following center lumen line reconstruction. These tech-
niques have been extensively validated, demonstrating
high rates of interobserver agreement for aortic diame-
ters, proximal neck length, angulation, and aneurysm
volume.10-13 Neck diameters were measured in two
perpendicular axes just distal to the lowermost renal
artery ostium and at every 5 mm distally along the first
15 mm of the infrarenal neck on center lumen line
reconstruction imaging.
Definitions. A patient was considered to have under-
gone standard EVAR if an infrarenal AAA had been
treated with any of the commercially available standard
infrarenal aortic endografts without planned adjuncts,
such as endoanchoring, parallel stent techniques, and
fenestrated or branched technology. Compliance with
device instructions for use was not mandatory. The
average of the two largest neck measurements obtained
in the infrarenal neck was considered the reference neck
diameter. For patients with a neck length <15 mm, the
average of the first two measurements was taken as
the reference diameter. This diameter was then used toselect the study group (diameter $30 mm) and to calcu-
late oversizing. Patients with a reference neck
diameter <30 mm were considered controls. Neck
configuration was classified according to published
methods.14 Aortic necks demonstrating progressive
diameter increments $10% along their length were
considered inverse-tapered neck (type II) configuration.
Circumferential involvement of thrombus or calcification
of the infrarenal neck was categorized into <25%, 25% to
50%, 50% to 75%, and >75%. Patients’ comorbidities and
aneurysm-related outcomes are presented according to
the Society for Vascular Surgery reporting standards.15,16
Accordingly, sac growth was defined as >5-mm-diam-
eter increase after EVAR. Renal insufficiency was
considered when the estimated glomerular filtration rate
(eGFR) was <60 mL/min/1.73 m2.
Institutional AAA management and postoperative
surveillance. During the studyperiod, treatment selection
was individualized but evolved toward a more primary
EVAR practice, particularly in patients without significant
anatomic restraints, patients with worse health status, or
patients with previous abdominal surgery (hostile
abdomen). The patient’s preference was also considered.
Typical follow-up protocols included 30-day and yearly
CT angiography. However, according to the treating
physician’s expectation, in selected patients with an
anticipated lower risk of complications or renal function
impairment, CT angiography was replaced by color
duplex ultrasound or noncontrast-enhanced CT.
Survival status and causes of death. Survival status and
cause of death were retrieved from the Dutch Central
Bureau of Statistics (study ID: 7465) for patients deceased
to December 2014. Each patient’s official death certifi-
cate report was matched to an anonymized database
of the study population. As determined by Dutch privacy
legislation, data analysis was allowed only to authorized
researchers (K.U., F.B.G.) and performed inside a secure
environment. All output was checked by the Central
Bureau of Statistics for privacy violation before it was
Table I. Baseline demographic, anatomic, and device-
related characteristics
Characteristics (N ¼ 404)
Age, years 72.6 (67.7)
Male sex 355 (87.9)
Hypertension 281 (69.6)
Diabetes mellitus 68 (16.8)
eGFR <60 mL/min/1.73 m2a 103 (25.5)
Previous history of smoking or continuous
smoking at time of implantationa
287 (71.0)
Cardiac status $2b 76 (18.8)
ASA class 3/4a 207 (51.2)
AAA diameter >70 mm 86 (21.3)
Infrarenal neck diameter $30 mm 55 (13.6)
Infrarenal neck length, mm 29.9 (614.4)
Reverse-tapered neck configuration 103 (25.5)
Neck thrombus >25% 369 (91.3)
Neck calcification >25% 372 (91.1)
a angle $45 degrees 46 (11.4)
b angle $60 degrees 77 (19.1)
Suprarenal fixation 221 (54.7)
Active (hooks) fixation 385 (95.3)
Endografts
Endurant (Medtronic, Santa Rosa, Calif) 198 (49.0)
Excluder (W. L. Gore & Associates,
Flagstaff, Ariz)
175 (43.3)
Talent (Medtronic) 12 (3.0)
Zenith (Cook Medical, Bloomington, Ind) 11 (2.7)
Others 8 (2.0)
Aneurysm sac growth 48 (11.9)
Endoleaksc 119 (29.5)
Type I or III 40 (9.9)
Type II 90 (22.3)
AAA, Abdominal aortic aneurysm; ASA, American Society of Anesthe-
siologists; eGFR, estimated glomerular filtration rate.
Continuous data are presented as mean (6standard deviation) and
categorical data as count/number of patients with available data
(percentage).
aMissing data for >3% to <6%.
bAccording to the Society for Vascular Surgery/American Association
for Vascular Surgery medical comorbidity grading system.
cCount is given as number of patients developing each type of
endoleak.
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not routinely performed, and the expected cause leading
to the initial health deterioration before death was
considered the true cause of death. The causes of death
were grouped according to the International Classifica-
tion of Diseases, Tenth Revision (ICD-10). The following
codes were used: for cardiovascular death, I10-I79; for
cancer-related death, C00-C43, C45-C97, D00-D03, and
D05-09; and for AAA-related death, I71.3, I71.4, I71.8, I71.9,
I72.3, and T82.7. The proportion of coding based on
autopsy vs clinical evaluation could not be determined.
End points. The primary study end points were
all-cause mortality and cardiovascular mortality. The
secondary end point was AAA-related mortality.
Statistical analysis. Baseline demographics, comorbid-
ities, and morphologic variables are presented as means
and standard deviation if continuous and normally
distributed or as count and percentage if categorical.
Differences were assessed using the Student t-test or
Pearson c2 test. Continuous variables with a skewed dis-
tribution are presented as median and interquartile
range and were compared using the Mann-Whitney U
test for independent samples. The association between
each of the baseline characteristics with all-cause mor-
tality and cardiovascular mortality was tested in Cox
proportional hazards regression univariable analyses.
Variables with P value #.1 were then entered into a
multivariable model, after which a final model was
obtained using stepwise backward elimination of vari-
ables with a P value >.05. The 95% confidence intervals
(CIs) were used, and statistical significance was consid-
ered for a < .05. Survival curves were estimated by
Kaplan-Meier methods, and equality was assessed with
the Mantel-Cox log-rank test. All statistical analyses were
performed using Statistical Package for Social Sciences
21.0 (IBM Corp, Chicago, Ill).
RESULTS
During the study period, 622 EVARs were performed; 82
ruptured AAAs, 33 anastomotic or other pseudoaneur-
ysms, 16 isolated iliac aneurysms, and 9 infectious and 1
traumatic ruptures were excluded. Among the remain-
ing cohort of 481 patients, 77 more patients were
excluded; 4 patients died during the hospital admission
for the primary procedure, and for 73, a complete
anatomic data set was not obtainable as baseline imag-
ing was no longer retrievable for analysis, leaving a final
population of 404 patients treated for intact degenera-
tive AAA with standard infrarenal EVAR. Baseline charac-
teristics are depicted in Table I.
All-cause mortality. During a median follow-up of
5.8 years (interquartile range, 3.1-7.4 years; maximum,
16.1 years; total person-years of 2292.22), 181 patients
died, resulting in a death incidence rate of 7.9 per 100person-years. The 5- and 10-year overall survival rates for
the entire population after EVAR were 70% (95% CI, 66%-
75%) and 43% (95% CI, 37%-50%), respectively. In the
univariable analysis, age, smoking, American Society of
Anesthesiologists class 3 or class 4, eGFR <60 mL/min/
1.73 m2, AAA diameter >70mm, infrarenal neck diameter
$30 mm, and >25% circumferential neck thrombus
were found to be risk factors for all-cause mortality. No
association was found between postimplantation sac
growth and overall mortality on univariable analysis
(P ¼ .21). Regarding anatomic characteristics, only
baseline AAA diameter >70 mm remained significant in
Table II. Risk factors for all-cause mortality
Variables Univariable P value
All-cause mortality
First model Final model
HR 95% CI P value HR 95% CI P value
Age (per year) <.001 1.06 1.03-1.08 <.001 1.06 1.04-1.09 <.001
Previous history of smoking or continuous
smoking at time of implantation
.075 1.32 0.87-2.01 .184 e e e
ASA class 3/4 .029 1.71 1.17-2.51 .006 1.78 1.23-2.56 .002
Renal insufficiency <.001 1.98 1.35-2.92 <.001 1.89 1.31-2.73 .001
AAA diameter >70 mm .01 1.49 1.00-2.25 .050 1.75 1.20-3.56 .004
Infrarenal neck diameter $30 mm .104 0.95 0.56-1.63 .862 e e e
Neck thrombus >25% .016 0.54 0.26-1.12 .096 e e e
AAA, Abdominal aortic aneurysm; ASA, American Society of Anesthesiologists; CI, confidence interval; HR, hazard ratio.
Multivariable regression performed with progressive backward stepwise modeling including variables with a < .1 in the first model and variables
a < .05 in the final model.
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1.20-3.56; Table II). In addition, age (HR, 1.06; 95% CI, 1.04-
1.09 per year), American Society of Anesthesiologists class
$3 (HR, 1.78; 95% CI, 1.23-2.56), and eGFR <60 mL/min/
1.73 m2 (HR, 1.89; 95% CI, 1.31-2.73) were significantly
associated with decreased survival.
Cardiovascular mortality. The cause of death was
obtainable for patients who died before the beginning
of 2015. Up to then, 158 patients had died among the
study cohort, and the cause of death was known for
156 of these patients (98.7%). Cardiovascular causes
were responsible for 60 deaths (38.5%), which included
6 aneurysm-related deaths (1.5%). In addition, 47 (30.1%)
were related to cancer, and 49 (31.4%) were due to other
causes. In the univariable analysis, age, male sex,
eGFR <60 mL/min/1.73 m2, AAA diameter >70 mm,
infrarenal neck diameter $30 mm, reverse-tapered neck
configuration, neck thrombus >25%, and a angle $45
degrees were found to be risk factors for cardiovascular
mortality (Table III). Postimplantation sac growth was not
associated with cardiovascular-related mortality in uni-
variable analysis (P ¼ .25). In the final multivariable
regression model, AAA diameter >70 mm (HR, 2.45; 95%
CI, 1.34-4.46) and neck diameter $30 mm (HR, 2.16; 95%
CI, 1.05-4.43) were associated with an increased risk of
cardiovascular mortality. Other independent predictors
of cardiovascular mortality were age (HR, 1.66; 95% CI,
1.15-2.41 per year), eGFR <60 mL/min/1.73 m2 (HR, 2.09;
95% CI, 1.19-3.65), and female sex (HR, 2.04; 95% CI, 1.08-
4.00). Infrarenal neck thrombus $25% (HR, 0.32; 95% CI,
0.13-0.77) was found to have a protective association.
Aneurysm-related mortality. Aneurysm-related causes
were responsible for six of the deaths (incidence rate
of 0.29 per 100 person-years). For two patients, the
reported main cause of death was vascular graft infec-
tion (ICD-10 code T82.7). These patients developed a type
IA endoleak and aneurysm rupture and died in theperioperative period after open conversion. Another two
patients had postprocedural complications of the circu-
latory system, unspecified (ICD-10 code I97.9). One of
these patients had developed a type IA endoleak and
underwent open conversion. This patient died 4 months
later after having been transferred to another health care
institution, but the exact cause of death could not be
obtained. The other patient presented with acute limb
ischemia due to endograft limb occlusion and died of
myocardial infarction in the perioperative period after a
successful thrombectomy. Finally, the cause of death of
the remaining two patients was classified as sequelae of
complications of surgical and medical care (ICD-10 code
T98.3). One of these patients had undergone a femoral-
femoral bypass because of acute limb ischemia a
month before and presented with thrombosis of the
crossover bypass. During the thrombectomy procedure,
this patient died of heart failure. The last patient with a
type IB endoleak detected on routine imaging surveil-
lance developed a type IA endoleak and AAA rupture
while awaiting treatment. As the type IA endoleak was
considered unsuitable to endovascular repair and the
patient was unfit for open repair, no intervention was
performed.
DISCUSSION
This study suggests that after standard EVAR for intact
AAA, the main causes of death are cardiovascular dis-
eases and cancer. Baseline AAA diameter >70 mm was
associated with both an increased risk of all-cause and
cardiovascular mortality after standard EVAR for intact
degenerative AAA. In addition, an increased risk of car-
diovascular mortality was found among patients with
neck diameters $30 mm, which was independent from
preoperative AAA diameter. However, this relative excess
of cardiovascular-related mortality in the wide infrarenal
neck group was not AAA related, implicating that preop-
erative presence of a wide proximal neck diameter did
Table III. Risk factors for cardiovascular-related mortality
Variables Univariable P value
Cardiovascular mortality
First model Final model
HR 95% CI P value HR 95% CI P value
Age (per year) .001 1.62 1.12-2.35 .011 1.66 1.15-2.41 .007
Female sex .026 0.48 0.25-0.92 .027 2.04 1.08-4.00 .030
Renal insufficiency .003 2.03 1.16-3.56 .013 2.09 1.19-3.65 .010
AAA diameter >70 mm .005 2.20 1.16-4.16 .016 2.45 1.34-4.46 .003
Infrarenal neck diameter $30 mm .104 1.98 1.00-4.10 .05 2.16 1.05-4.43 .037
Reverse-tapered neck configuration .054 1.44 0.80-2.61 .227 e e e
Neck thrombus >25% .004 0.31 0.12-0.76 .011 0.32 0.13-0.77 .011
a angle $45 degrees .054 1.39 0.66-2.94 .39 e e e
AAA, Abdominal aortic aneurysm; CI, confidence interval; HR, hazard ratio.
Multivariable regression performed with progressive backward stepwise modeling including variables with a < .1 in the first model and variables
a < .05 in the final model.
Cause of death was known for 156 of 158 patients who were deceased to the end of 2014, 19 in the $30-mm neck diameter group and 139 in the
control group.
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threatening complications.
Contemporary management of AAA patients who
reach a repair threshold involves a complex decision-
making process in which demographics, comorbidities,
anatomic features, operative risk, vital prognosis, and
patients’ preferences are considered. The reduced overall
survival of AAA patients after repair compared with age-
and sex-matched counterparts has been reported and
has been attributed to cardiovascular events.1,17 More
recently, some studies have suggested a change in the
epidemiology, with other competing health risks, such
as cancer, gaining a greater preponderance among
death causes of AAA patients.2 Yet, as arterial aneurysmal
disease and atherosclerosis share most of the previously
established risk factors, it is not surprising that cardiovas-
cular diseases are still one of the main causes of death
among these patients.18,19 In a systematic review from
Khashram et al,3 several risk factors (hypertension, hyper-
lipidemia, tobacco abuse) and comorbidities (cardiac
disease, cerebrovascular disease, renal insufficiency, pul-
monary disease) were independently linked to the exces-
sive mortality found in AAA patients, which parallels the
results reported in our study. In addition, sex-related dis-
parities have been extensively reported regarding periop-
erative EVAR outcomes and long-term survival, generally
disfavorable for women.20,21 In our report, female sex was
also associated with an increased risk of cardiovascular
mortality.
In addition to demographics and patients’ comorbid-
ities, some anatomic features, such as arterial calcifica-
tion and in particular abdominal aortic calcification,
have been found to influence survival in the general
population as well as in populations with aortic aneu-
rysms.7,22,23 In our study, only aortic neck calcification
was assessed, with no association with survival found.More important, AAA diameter has also been associated
with a worse survival by several authors, including a sys-
tematic review and meta-analysis from Bahia et al.24,25
Among EVAR patients, Huang et al26 observed an
increased risk ofmortality in adjusted analyses of patients
withAAAdiameters>6.0 cm (HR, 2.0; 95%CI, 1.4-2.9). Simi-
larly, Leurs et al27 had foundan8-year survival rate of 49.6%
among patients with AAA diameters $55 mm (n ¼ 609),
which was also significantly shorter compared with the
remaining cohort (74.5% [n ¼ 581]; P < .001). However, in
the report from Leurs et al, an excess of aneurysm-
related mortality was reported among the $55-mm AAA
diameter group (21.2% vs 5.7% in the <55-mm group;
P < .001), which contributed to the observed survival dif-
ference, possibly related to the inclusion of older genera-
tion devices that were more prone to fail compared with
more recent endografts.28 To overcome this limitation,
Waasdorp et al8 analysed a subgroup of patients from
the European Collaborators on Stent/graft Techniques
for aortic Aneurysm Repair (EUROSTAR) registry treated
only with a single second-generation device (Talent; Med-
tronic, Santa Rosa, Calif). Still, an increased mortality was
reported among patients with AAA diameters >60 mm
and infrarenal neck diameters >26 mm (P ¼ .002). Never-
theless, these patients also suffered from a higher rate of
aneurysm-related complications, including type I endo-
leaks, open conversion, and aneurysm rupture. Interest-
ingly, in a study from Brady et al29 reporting on the UK
Small Aneurysm Trial and study cohort, patients with
larger AAA diameters were found to have a higher risk of
cardiovascular mortality (not aneurysm related) both
before (odds ratio, 1.3; 95% CI, 1.0-1.8 per 0.8 cm of AAA
diameter increase) and after AAA repair (odds ratio, 1.3;
95%CI, 1.1-1.6 per 0.8 cmofAAAdiameter increase). Impor-
tantly, in this study, all aneurysm-related deaths had been
excluded from the analyses. Similarly, in our study, AAA
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vival and increased risk of cardiovascular death. Note-
worthy, our analyses adjusted not only for differences in
demographics and comorbidities but also for other
morphologic characteristics as well. Consequently, our
results suggest that factors related to the size of the aneu-
rysm itselfmay play a role in the excessivemortality found
among these patients. Increased wall inflammation and
serum level of high-sensitivity C-reactive protein have
been identified among patients with larger aortic aneu-
rysms.30,31 Furthermore, systemic inflammation has been
associated with increased mortality in the long term
among patients with atherosclerotic disease.32 Conse-
quently, onemay speculate that the survival disadvantage
found among patients with larger AAA diameters sug-
gests that the aneurysm itself may play a biologically
active role as a source of inflammation. Still, although
more robust data are not available, patients with large
AAA size still have a shorter survival compared with
patients with smaller AAA diameters, greatly related to a
higher risk of cardiovascular death. Consequently,
although it is not recommended in practice guidelines, a
more intensivemanagementof thesepatients’ comorbid-
ities with inclusion of routine high-dose statin therapy
with the purpose of lowering cardiovascular risk may be
justified in this particular group of AAA patients.33 In this
report, we also investigated the importance of infrarenal
neck diameter. The association between large (>26 mm)
infrarenal aortic necks and worse survival had been previ-
ously reported byWaasdorp et al. However, alongwith the
limitations listedbefore, the exact causes of deathof these
patients were not reported. More important, the authors
included patients with both infrarenal neck diameter
>26mmandAAAdiameter>60mmbut did not perform
multivariable analysis, so the independent influence of
each of these characteristics on survival could not be
determined. In our study, the reported causes of
death were obtained. Furthermore, infrarenal aortic neck
diameter was found to be related to an increased risk of
cardiovascular mortality, which was not AAA related.
Moreover, this effect was independent from AAA diam-
eter. Therefore, our results suggest that larger infrarenal
neck diameters are an additional anatomic marker of a
more frail overall health status. Like patients with large
AAA diameters, these patients might also benefit from a
more intensive management of their comorbidities and
from routine high-dose statin therapy.
Aortic thrombus is another characteristic that has been
associated with decreased survival after EVAR.9,34 In a
report from Parr et al34 (N ¼ 98), AAA thrombus volume
$25 cm3 was identified as an independent risk factor
for cardiovascular events (relative risk, 2.3; 95% CI,
1.0-5.2). Nevertheless, as reported by the same group in
a separate publication, thrombus volume and AAA size
are highly correlated (r ¼ 0.74; P < .0001), which
limits their results, as they suggest that significantinteraction may have been present in their multivariable
modeling.34,35 In another report focusing on mural
thrombus of the thoracic and visceral aorta,
Kwon et al9 reported a shorter overall survival (mean,
64.1 6 5.7 months) for patients with greater aortic
thrombus burdens (“shaggy aorta”) compared with the
remaining cohort (mean, 81.5 6 1.5 months; P ¼ .005).
However, these findings lost their statistical significance
in multivariable analyses, suggesting that potential con-
founders may be responsible for their findings. Paradox-
ically, in our study, patients with >25% circumferential
thrombus in the infrarenal aortic neck were found to
have a decreased risk of cardiovascular death in multivar-
iable analysis, which was not anticipated and warrants
caution in interpretation. However, as we did not assess
the presence of aortic thrombus in other segments, we
cannot determine whether infrarenal neck thrombus
was associated with greater thrombus burden in the
thoracic and suprarenal abdominal aorta. Future investi-
gation should be performed to clarify these findings.
The reported crude death rates after EVAR for intact
AAA are subject to some variation throughout the litera-
ture. Among the randomized controlled trials (RCTs), the
overall mortality was 11.3% in the Anevrysme de l’aorte
abdominale: Chirurgie versus Endoprothese (ACE) trial
during a median follow-up of 3 years, 31.1% in the Dutch
Randomized Endovascular Aneurysm Management
(DREAM) trial after a median follow-up of 6.4 years,
39.2% in the Open Versus Endovascular Repair (OVER)
trial at a mean follow-up of 5.2 years, and 53% beyond
the eighth year of follow-up in the UK EndoVascular
Aneurysm Repair (EVAR 1) trial.36-39 Regarding registry
databases, Schermerhorn et al40 reported an 8-year
death rate of 54.9% among 39,966 Medicare patients
treated by EVAR, which parallels the EVAR 1 trial data.
In the Swedish population, Mani et al1 found a 5-year
death rate of 25.9% among 855 EVAR patients, which
was lower than in the previously cited studies and sug-
gested that long-term survival had improved in more
recent years. In two separate meta-analyses including
the aforementioned reports, the overall mortality was
found to be 31% at 5-year follow-up and 34.7% at 4-year
follow-up, respectively.3,41 In our study, the crude mortal-
ity rate (mean, 7.7%/y) is within the range of the reported
meta-analyses but higher than in the RCTs, which may
be the consequence of comorbidities and life expec-
tancy differences in these populations.
Aneurysm-related mortality was responsible for 1.5% of
the deaths in our population, which is similar to the rates
reported in the RCTs. In the ACE trial, 2% of the EVAR
patients died of aneurysm-related causes, whereas in
the OVER trial, a comparable 1.8% of aneurysm-related
deaths was also found but during a longer follow-up
time (median of 3 years vs mean of 5.2 years, respectively).
In the EVAR 1 trial, the incidence rate of aneurysm-related
mortality was 0.6 per 100 person-years from 6 months to
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May 20194-year follow-up and increased to0.9 per 100person-years
during the 4- to 8-year period. In comparison to theEVAR 1
trial, our study shows a lower rate of aneurysm-related
deaths (0.29 per 100 person-years). This discrepancy may
well be due to improved selection of patients and better
performance of later generation endografts.28 However,
these data should be interpreted with caution because
of the low number of events and because four periopera-
tive (AAA-related) deathswere excluded fromour analysis.
Consequently we were not able to determine the impor-
tance of each of the studied morphologic characteristics
on aneurysm-related mortality.
Other noteworthy limitations of this study include its
retrospective design and the inclusion of patients
treated at a single center, which may have introduced
a selection bias. In addition, autopsies are not routinely
performed in The Netherlands, which may have limited
the diagnostic accuracy and consequent codification of
cause of death, particularly for the AAA-related deaths.
It was not possible to determine the proportion of
deaths coded on the basis of autopsy in this study.
Nevertheless, the causes of death were obtained from
the Central Bureau of Statistics and were available for
99% of those patients who died before the start of
2015; these are the most reliable mortality data available
in The Netherlands, a country with a recognized strict
policy of rigor in reporting causes of death. The accuracy
of cause of death coding in The Netherlands has been
previously investigated and was found to be higher
than 90%.42 Still, we suggest that data regarding cause
of death be carefully interpreted, taking into account
the potential for some degree of misdiagnosis to be
present. Also, our results may not be applicable to non-
Western European populations with different genetic
and environmental backgrounds, to other populations
in whom secondary prevention differs from the stan-
dards of practice in The Netherlands, or to other popula-
tions with greatly different disease incidences. Also
important, the exclusion of patients who died during
the index hospitalization for EVAR or for whom a preop-
erative CT image was not retrievable for analysis may
constitute a selection bias. Finally, all patients included
were from a tertiary center with expertise in AAA
management, which may limit the generalizability of
our findings to other centers.
CONCLUSIONS
This study suggests that patients with AAA diameters
>70 mm are at increased risk of all-cause and cardiovas-
cular mortality. In addition, patients with infrarenal neck
diameters $30 mm had a greater risk of cardiovascular
mortality. Importantly, this relative excess of cardiovascu-
lar mortality was not AAA related. Consequently, patients
with large AAA diameter and wider neck diameters may
warrant a more aggressive management of their medical
comorbidities to improve survival after EVAR.AUTHOR CONTRIBUTIONS
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